ferrous succinate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4544 10030-90-7

Description:

MoleculeDescription

Synonyms:

  • ferrous succinate
  • iron succinate
  • Molecular weight: 171.92
  • Formula: C4H4FeO4
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 80.26
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
0.20 g O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Appendicolith 177.81 136.08 58 3177 13398 42604702
Myasthenia gravis 155.92 136.08 55 3180 16082 42602018
Appendicitis 153.61 136.08 58 3177 20555 42597545
Hyperphosphataemia 143.69 136.08 49 3186 12955 42605145
Blood phosphorus increased 141.54 136.08 48 3187 12477 42605623

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Appendicolith 227.93 111.25 58 3247 14197 110571797
Myasthenia gravis 190.80 111.25 55 3250 21456 110564538
Appendicitis 188.24 111.25 58 3247 28406 110557588
Blood phosphorus increased 173.05 111.25 48 3257 16292 110569702
Hyperphosphataemia 172.94 111.25 48 3257 16333 110569661
Ventricular fibrillation 159.31 111.25 56 3249 41257 110544737
Blood uric acid increased 151.36 111.25 46 3259 21483 110564511
Hypophosphataemia 139.55 111.25 48 3257 33134 110552860
Cardiogenic shock 134.45 111.25 54 3251 57284 110528710
Neuralgia 128.87 111.25 50 3255 48428 110537566
Ascites 121.58 111.25 58 3247 92750 110493244
Analgesic therapy 118.13 111.25 30 3275 7254 110578740
Bacterial infection 117.12 111.25 46 3259 45990 110540004
Incorrect route of product administration 115.40 111.25 50 3255 64011 110521983
Stress 111.67 111.25 57 3248 105291 110480703

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B03AA06 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron bivalent, oral preparations
MeSH PA D006397 Hematinics
MeSH PA D006401 Hematologic Agents
CHEBI has role CHEBI:75835 anti-anaemic agent

Related Drugs by ATC class:

B03AA Iron bivalent, oral preparations 8 drugs
ferrous ascorbateferrous aspartateferrous carbonateferrous chlorideferrous fumarateferrous gluconateferrous sulfateferrous tartrate

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEBI:755744 CHEBI
CHEMBL3707232 ChEMBL_ID
C022943 MESH_SUPPLEMENTAL_RECORD_UI
DB14489 DRUGBANK_ID
818ZYK7N91 UNII
24946 RXNORM
004130 NDDF
327432002 SNOMEDCT_US
419213004 SNOMEDCT_US
C0060281 UMLSCUI
10464762 PUBCHEM_CID

Pharmaceutical products:

None